Literature DB >> 22814462

Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.

James E Ross1, Helio S Sader, Zrinka Ivezic-Schoenfeld, Susanne Paukner, Ronald N Jones.   

Abstract

MIC and disk diffusion quality control (QC) ranges were established for two new pleuromutilin antimicrobials (BC-3205 and BC-3781) in an eight-laboratory study performed according to Clinical and Laboratory Standards Institute M23-A3 guidelines. Staphylococcus aureus ATCC 29213 and 25923, Streptococcus pneumoniae ATCC 49619, and Haemophilus influenzae ATCC 4927 strains were evaluated. The proposed QC ranges would aid clinical laboratories in testing these compounds following their development for treatment of respiratory and cutaneous infections.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22814462      PMCID： PMC3457460          DOI： 10.1128/JCM.01294-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections.

Authors:  Helio S Sader; Douglas J Biedenbach; Susanne Paukner; Zrinka Ivezic-Schoenfeld; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

2.  Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).

Authors:  Helio S Sader; Susanne Paukner; Zrinka Ivezic-Schoenfeld; Douglas J Biedenbach; Franz J Schmitz; Ronald N Jones
Journal:  J Antimicrob Chemother       Date:  2012-01-27       Impact factor: 5.790

3.  Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods.

Authors:  James E Ross; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing.

Authors:  John Turnidge; Gerry Bordash
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

Review 5.  The pleuromutilin antibiotics: a new class for human use.

Authors:  Rodger Novak; David M Shlaes
Journal:  Curr Opin Investig Drugs       Date:  2010-02
  5 in total
  1 in total

Review 1.  Advances in MRSA drug discovery: where are we and where do we need to be?

Authors:  Michio Kurosu; Shajila Siricilla; Katsuhiko Mitachi
Journal:  Expert Opin Drug Discov       Date:  2013-07-06       Impact factor: 6.098
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.